LifeStance Health (LFST) Shares Outstanding (Weighted Average) (2020 - 2026)

LifeStance Health (LFST) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $387.3 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $387.3 million, up 1.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $387.3 million (up 1.04% YoY), and the FY2025 annual result was $386.0 million, up 1.81% from the prior year.
• Shares Outstanding (Weighted Average) held at $387.3 million in Q1 2026 per LFST's latest filing, from $386.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $387.3 million in Q1 2026 and troughed at $350849.0 in Q1 2022.
• A 5-year average of $309.5 million and a median of $376.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) surged 108374.21% in 2022, then rose 1.04% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $355.3 million in 2022, then grew by 3.43% to $367.5 million in 2023, then advanced by 3.18% to $379.1 million in 2024, then increased by 1.81% to $386.0 million in 2025, then advanced by 0.32% to $387.3 million in 2026.
• Business Quant data shows LFST's Shares Outstanding (Weighted Average) at $387.3 million in Q1 2026, $386.0 million in Q4 2025, and $385.7 million in Q3 2025.